Europe Organoids Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

No. of Pages: 150    |    Report Code: TIPRE00018856    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Organoids Market

1.           Introduction

1.1       Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1           Hypothesis formulation:

3.2.2           Macro-economic factor analysis:

3.2.3           Developing base number:

3.2.4           Data Triangulation:

3.2.5           Country level data:

4.           Europe Organoids Market – Key Market Dynamics

4.1       Market Drivers

4.1.1           Increasing Demand for Tumor Modeling and Biobanking

4.1.2           Surging Adoption of Personalized Drugs

4.2       Market Restraints

4.2.1           Dearth of Skilled Professionals

4.3       Market Opportunities

4.3.1           Focus on Drug Discovery Activities

4.4       Future Trends

4.4.1           Combination of Organoids and Organ-on-a-Chip

4.5       Impact of Drivers and Restraints:

5.           Organoids Market – Europe Analysis

5.1       Europe Organoids Market Revenue (US$ Million), 2021–2031

5.2       Europe Organoids Market Forecast Analysis

6.           Europe Organoids Market Analysis – by Type

6.1       Intestine

6.1.1           Overview

6.1.2           Intestine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.2       Liver

6.2.1           Overview

6.2.2           Liver: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.3       Stomach

6.3.1           Overview

6.3.2           Stomach: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.4       Pancreas

6.4.1           Overview

6.4.2           Pancreas: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.5       Lung

6.5.1           Overview

6.5.2           Lung: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.6       Brain

6.6.1           Overview

6.6.2           Brain: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.7       Kidney

6.7.1           Overview

6.7.2           Kidney: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.8       Others

6.8.1           Overview

6.8.2           Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.           Europe Organoids Market Analysis – by Application

7.1       Developmental Biology Disease

7.1.1           Overview

7.1.2           Developmental Biology Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2       Pathology of Infectious Disease

7.2.1           Overview

7.2.2           Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.3       Regenerative Medicine

7.3.1           Overview

7.3.2           Regenerative Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.4       Drug Toxicity and Efficacy Testing

7.4.1           Overview

7.4.2           Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.5       Drug Discovery and Personalized Medicine

7.5.1           Overview

7.5.2           Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.6       Others

7.6.1           Overview

7.6.2           Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.           Europe Organoids Market Analysis – by Source

8.1       Pluripotent Stem Cells

8.1.1           Overview

8.1.2           Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2       Organ-Specific Adult Stem Cell

8.2.1           Overview

8.2.2           Organ-Specific Adult Stem Cell: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.           Europe Organoids Market Analysis – by Offering

9.1       Instruments

9.1.1           Overview

9.1.2           Instruments: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2       Consumables

9.2.1           Overview

9.2.2           Consumables: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3       Services

9.3.1           Overview

9.3.2           Services: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.        Europe Organoids Market Analysis – by Method

10.1     Micropatterned Plates

10.1.1         Overview

10.1.2         Micropatterned Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.2     Ultralow Attachment Plates

10.2.1         Overview

10.2.2         Ultralow Attachment Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3     Hanging Drop

10.3.1         Overview

10.3.2         Hanging Drop: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4     Microdroplet or Emulsion

10.4.1         Overview

10.4.2         Microdroplet or Emulsion: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.5     Others

10.5.1         Overview

10.5.2         Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.        Europe Organoids Market – Country Analysis

11.1     Europe

11.1.1         Europe Organoids Market – Revenue and Forecast Analysis – by Country

11.1.1.1     Europe Organoids Market – Revenue and Forecast Analysis – by Country

11.1.1.2     Germany: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.2.1     Germany: Europe Organoids Market Share – by Type

11.1.1.2.2     Germany: Europe Organoids Market Share – by Application

11.1.1.2.3     Germany: Europe Organoids Market Share – by Source

11.1.1.2.4     Germany: Europe Organoids Market Share – by Offering

11.1.1.2.5     Germany: Europe Organoids Market Share – by Instruments

11.1.1.2.6     Germany: Europe Organoids Market Share – by Consumables

11.1.1.2.7     Germany: Europe Organoids Market Share – by Method

11.1.1.3     France: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.3.1     France: Europe Organoids Market Share – by Type

11.1.1.3.2     France: Europe Organoids Market Share – by Application

11.1.1.3.3     France: Europe Organoids Market Share – by Source

11.1.1.3.4     France: Europe Organoids Market Share – by Offering

11.1.1.3.5     France: Europe Organoids Market Share – by Instruments

11.1.1.3.6     France: Europe Organoids Market Share – by Consumables

11.1.1.3.7     France: Europe Organoids Market Share – by Method

11.1.1.4     United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.4.1     United Kingdom: Europe Organoids Market Share – by Type

11.1.1.4.2     United Kingdom: Europe Organoids Market Share – by Application

11.1.1.4.3     United Kingdom: Europe Organoids Market Share – by Source

11.1.1.4.4     United Kingdom: Europe Organoids Market Share – by Offering

11.1.1.4.5     United Kingdom: Europe Organoids Market Share – by Instruments

11.1.1.4.6     United Kingdom: Europe Organoids Market Share – by Consumables

11.1.1.4.7     United Kingdom: Europe Organoids Market Share – by Method

11.1.1.5     Italy: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.5.1     Italy: Europe Organoids Market Share – by Type

11.1.1.5.2     Italy: Europe Organoids Market Share – by Application

11.1.1.5.3     Italy: Europe Organoids Market Share – by Source

11.1.1.5.4     Italy: Europe Organoids Market Share – by Offering

11.1.1.5.5     Italy: Europe Organoids Market Share – by Instruments

11.1.1.5.6     Italy: Europe Organoids Market Share – by Consumables

11.1.1.5.7     Italy: Europe Organoids Market Share – by Method

11.1.1.6     Spain: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.6.1     Spain: Europe Organoids Market Share – by Type

11.1.1.6.2     Spain: Europe Organoids Market Share – by Application

11.1.1.6.3     Spain: Europe Organoids Market Share – by Source

11.1.1.6.4     Spain: Europe Organoids Market Share – by Offering

11.1.1.6.5     Spain: Europe Organoids Market Share – by Instruments

11.1.1.6.6     Spain: Europe Organoids Market Share – by Consumables

11.1.1.6.7     Spain: Europe Organoids Market Share – by Method

11.1.1.7     Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

11.1.1.7.1     Rest of Europe: Europe Organoids Market Share – by Type

11.1.1.7.2     Rest of Europe: Europe Organoids Market Share – by Application

11.1.1.7.3     Rest of Europe: Europe Organoids Market Share – by Source

11.1.1.7.4     Rest of Europe: Europe Organoids Market Share – by Offering

11.1.1.7.5     Rest of Europe: Europe Organoids Market Share – by Instruments

11.1.1.7.6     Rest of Europe: Europe Organoids Market Share – by Consumables

11.1.1.7.7     Rest of Europe: Europe Organoids Market Share – by Method

12.        Industry Landscape

12.1     Overview

12.2     Growth Strategies in Organoids Market

12.3     Organic Growth Strategies

12.3.1         Overview

12.4     Inorganic Growth Strategies

12.4.1         Overview

13.        Company Profiles

13.1     STEMCELL Technologies Inc

13.1.1         Key Facts

13.1.2         Business Description

13.1.3         Products and Services

13.1.4         Financial Overview

13.1.5         SWOT Analysis

13.1.6         Key Developments

13.2     Molecular Devices, LLC.

13.2.1         Key Facts

13.2.2         Business Description

13.2.3         Products and Services

13.2.4         Financial Overview

13.2.5         SWOT Analysis

13.2.6         Key Developments

13.3     Hubrecht Organoid Technology

13.3.1         Key Facts

13.3.2         Business Description

13.3.3         Products and Services

13.3.4         Financial Overview

13.3.5         SWOT Analysis

13.3.6         Key Developments

13.4     Definigen

13.4.1         Key Facts

13.4.2         Business Description

13.4.3         Products and Services

13.4.4         Financial Overview

13.4.5         SWOT Analysis

13.4.6         Key Developments

13.5     Organoid Therapeutics

13.5.1         Key Facts

13.5.2         Business Description

13.5.3         Products and Services

13.5.4         Financial Overview

13.5.5         SWOT Analysis

13.5.6         Key Developments

13.6     Thermo Fisher Scientific Inc

13.6.1         Key Facts

13.6.2         Business Description

13.6.3         Products and Services

13.6.4         Financial Overview

13.6.5         SWOT Analysis

13.6.6         Key Developments

13.7     Corning Inc

13.7.1         Key Facts

13.7.2         Business Description

13.7.3         Products and Services

13.7.4         Financial Overview

13.7.5         SWOT Analysis

13.7.6         Key Developments

13.8     Merck KGaA

13.8.1         Key Facts

13.8.2         Business Description

13.8.3         Products and Services

13.8.4         Financial Overview

13.8.5         SWOT Analysis

13.8.6         Key Developments

13.9     InSphero

13.9.1         Key Facts

13.9.2         Business Description

13.9.3         Products and Services

13.9.4         Financial Overview

13.9.5         SWOT Analysis

13.9.6         Key Developments

13.10  ACRO Biosystems.

13.10.1      Key Facts

13.10.2      Business Description

13.10.3      Products and Services

13.10.4      Financial Overview

13.10.5      SWOT Analysis

13.10.6      Key Developments

13.11  Bio-Techne Corp

13.11.1      Key Facts

13.11.2      Business Description

13.11.3      Products and Services

13.11.4      Financial Overview

13.11.5      SWOT Analysis

13.11.6      Key Developments

13.12  SUN bioscience SA

13.12.1      Key Facts

13.12.2      Business Description

13.12.3      Products and Services

13.12.4      Financial Overview

13.12.5      SWOT Analysis

13.12.6      Key Developments

13.13  ORGANOID SCIENCES Co., Ltd.

13.13.1      Key Facts

13.13.2      Business Description

13.13.3      Products and Services

13.13.4      Financial Overview

13.13.5      SWOT Analysis

13.13.6      Key Developments

13.14  Crown Bioscience Inc

13.14.1      Key Facts

13.14.2      Business Description

13.14.3      Products and Services

13.14.4      Financial Overview

13.14.5      SWOT Analysis

13.14.6      Key Developments

13.15  Sartorius AG

13.15.1      Key Facts

13.15.2      Business Description

13.15.3      Products and Services

13.15.4      Financial Overview

13.15.5      SWOT Analysis

13.15.6      Key Developments

13.16  3D Biotek LLC

13.16.1      Key Facts

13.16.2      Business Description

13.16.3      Products and Services

13.16.4      Financial Overview

13.16.5      SWOT Analysis

13.16.6      Key Developments

13.17  Prellis Biologics Inc.

13.17.1      Key Facts

13.17.2      Business Description

13.17.3      Products and Services

13.17.4      Financial Overview

13.17.5      SWOT Analysis

13.17.6      Key Developments

13.18  3Dnamics Inc.

13.18.1      Key Facts

13.18.2      Business Description

13.18.3      Products and Services

13.18.4      Financial Overview

13.18.5      SWOT Analysis

13.18.6      Key Developments

13.19  Cellesce Ltd

13.19.1      Key Facts

13.19.2      Business Description

13.19.3      Products and Services

13.19.4      Financial Overview

13.19.5      SWOT Analysis

13.19.6      Key Developments

14.        Appendix

14.1     About The Insight Partners

List of Tables

Table 1.             Europe Organoids Market Segmentation

Table 2.             Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3.             Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type

Table 4.             Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application

Table 5.             Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Source

Table 6.             Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Offering

Table 7.             Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Method

Table 8.             Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 9.             Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 10.          Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 11.          Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 12.          Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 13.          Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 14.          Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 15.          Germany: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 16.          France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 17.          France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 18.          France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 19.          France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 20.          France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 21.          France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 22.          France: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 23.          United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 24.          United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 25.          United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 26.          United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 27.          United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 28.          United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 29.          United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 30.          Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 31.          Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 32.          Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 33.          Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 34.          Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 35.          Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 36.          Italy: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 37.          Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 38.          Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 39.          Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 40.          Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 41.          Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 42.          Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 43.          Spain: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 44.          Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 45.          Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 46.          Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Source

Table 47.          Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Offering

Table 48.          Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Instruments

Table 49.          Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Consumables

Table 50.          Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Method

Table 51.          Recent Organic Growth Strategies in Organoids Market

Table 52.          Recent Inorganic Growth Strategies in the Organoids Market

List of Figures

Figure 1.           Europe Organoids Market Segmentation – Country

Figure 2.           Europe Organoids Market – Key Market Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           Europe Organoids Market Revenue (US$ Million), 2021–2031

Figure 5.           Europe Organoids Market Share (%) – by Type (2023 and 2031)

Figure 6.           Intestine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 7.           Liver: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8.           Stomach: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9.           Pancreas: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10.        Lung: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11.        Brain: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12.        Kidney: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13.        Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14.        Europe Organoids Market Share (%) – by Application (2023 and 2031)

Figure 15.        Developmental Biology Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16.        Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17.        Regenerative Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18.        Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19.        Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20.        Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 21.        Europe Organoids Market Share (%) – by Source (2023 and 2031)

Figure 22.        Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 23.        Organ-Specific Adult Stem Cell: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 24.        Europe Organoids Market Share (%) – by Offering (2023 and 2031)

Figure 25.        Instruments: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 26.        Consumables: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 27.        Services: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 28.        Europe Organoids Market Share (%) – by Method (2023 and 2031)

Figure 29.        Micropatterned Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 30.        Ultralow Attachment Plates: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 31.        Hanging Drop: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 32.        Microdroplet or Emulsion: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 33.        Others: Europe Organoids Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 34.        Europe Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 35.        Germany: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 36.        France: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 37.        United Kingdom: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 38.        Italy: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 39.        Spain: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 40.        Rest of Europe: Europe Organoids Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 41.        Growth Strategies in Organoids Market

The List of Companies - Europe Organoids Market

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd